{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:02:31Z","timestamp":1793318551467,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bbmt.2019.07.034","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T01:51:37Z","timestamp":1564969897000},"page":"e321-e330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy"],"prefix":"10.1016","volume":"25","author":[{"given":"Steven A.","family":"Pergam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"Englund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mini","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9190-263X","authenticated-orcid":false,"given":"Hayley A.","family":"Gans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin","family":"Savani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy F.","family":"Chemaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeet S.","family":"Dadwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Storek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Duchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.07.034_bib0001","unstructured":"World Health Organization. Measles cases spike globally due to gaps in vaccination coverage. Available at: https:\/\/www.who.int\/news-room\/detail\/29-11-2018-measles-cases-spike-globally-due-to-gaps-in-vaccination-coverage. Accessed 20 July 2019."},{"key":"10.1016\/j.bbmt.2019.07.034_bib0002","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jama.2016.1353","article-title":"Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis","volume":"315","author":"Phadke","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0003","first-page":"153","article-title":"Measles outbreak\u2014California, December 2014-February 2015","volume":"64","author":"Zipprich","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0004","doi-asserted-by":"crossref","first-page":"402","DOI":"10.15585\/mmwr.mm6817e1","article-title":"Increase in measles cases\u2014United States, January 1-April 26, 2019","volume":"68","author":"Patel","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0005","article-title":"The state of the antivaccine movement in the United States: a focused examination of nonmedical exemptions in states and counties","volume":"15","author":"Olive","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0006","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/infdis\/jiv271","article-title":"Whole-genome sequencing of measles virus genotypes H1 and D8 during outbreaks of infection following the 2010 Olympic Winter Games reveals viral transmission routes","volume":"212","author":"Gardy","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0007","doi-asserted-by":"crossref","first-page":"713","DOI":"10.15585\/mmwr.mm6627a1","article-title":"Measles outbreak - Minnesota April-May 2017","volume":"66","author":"Hall","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0008","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/INF.0000000000002221","article-title":"Measles hospitalizations at a United States children's hospital 2011-2017","volume":"38","author":"Hester","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0009","doi-asserted-by":"crossref","first-page":"446","DOI":"10.15585\/mmwr.mm6819a5","article-title":"Notes from the field: community outbreak of measles\u2014Clark County, Washington, 2018-2019","volume":"68","author":"Carlson","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.15585\/mmwr.mm6819a4","article-title":"Notes from the field: measles outbreaks from imported cases in Orthodox Jewish communities\u2014New York and New Jersey, 2018-2019","volume":"68","author":"McDonald","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0011","unstructured":"Centers for Disease Control and Prevention. Measles cases and outbreaks. Available at: https:\/\/www.cdc.gov\/measles\/cases-outbreaks.html. Accessed 28 August 2019"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0012","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1473-3099(19)30231-2","article-title":"Measles resurgence in the USA: how international travel compounds vaccine resistance","volume":"19","author":"Sarkar","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0013","doi-asserted-by":"crossref","first-page":"E277","DOI":"10.33321\/cdi.2012.36.22","article-title":"Measles with a possible 23 day incubation period","volume":"36","author":"Fitzgerald","year":"2012","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0014","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00430-016-0451-4","article-title":"Eradication of measles: remaining challenges","volume":"205","author":"Holzmann","year":"2016","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0016","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.vaccine.2013.02.026","article-title":"What the world's religions teach, applied to vaccines and immune globulins","volume":"31","author":"Grabenstein","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0017","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00006454-199907000-00010","article-title":"Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine","volume":"18","author":"Vitek","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0018","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/INF.0b013e31823cbaa5","article-title":"Comparative coverage of supplementary and universally recommended immunizations in children at 24 months of age","volume":"31","author":"Hug","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0019","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/10245332.2018.1460035","article-title":"Humoral immune response of childhood acute lymphoblastic leukemia survivors against the measles, mumps, and rubella vaccination","volume":"23","author":"Fouda","year":"2018","journal-title":"Hematology"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/cncr.20384","article-title":"Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy","volume":"101","author":"Zignol","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0021","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/sj.leu.2404326","article-title":"Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review","volume":"20","author":"van Tilburg","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0022","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/pbc.22135","article-title":"Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type B in children with acute lymphoblastic leukemia and response to re-vaccination","volume":"53","author":"Zengin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0023","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/08880011003767720","article-title":"Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia","volume":"27","author":"Aytac","year":"2010","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0024","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/08880011003621752","article-title":"Recovery of humoral and cellular immunities to vaccine-preventable infectious diseases in pediatric oncology patients","volume":"27","author":"Cheng","year":"2010","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0025","first-page":"481","article-title":"Measles and rubella antibody status in children after treatment for acute lymphoblastic leukemia","volume":"82","author":"Volc","year":"2006","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0026","first-page":"211","article-title":"[Presence of measles virus antibodies in a group of patients with malignant hemopathy]","volume":"52","author":"Ribas","year":"2000","journal-title":"Rev Cubana Med Trop"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0027","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/159.4.610","article-title":"Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine","volume":"159","author":"Ljungman","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0028","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood-2015-12-550475","article-title":"How I vaccinate blood and marrow transplant recipients","volume":"127","author":"Carpenter","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0029","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/sj.bmt.1704476","article-title":"Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants","volume":"33","author":"Spoulou","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0030","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.bbmt.2015.08.010","article-title":"Robust vaccine responses in adult and pediatric cord blood transplantation recipients treated for hematologic malignancies","volume":"21","author":"Shah","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0031","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bbmt.2019.04.006","article-title":"Safety and seropositivity after live attenuated vaccine in adult patients receiving hematopoietic stem cell transplantation","volume":"25","author":"Aoki","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112014","article-title":"Inhibitors of the interferon response enhance virus replication in vitro","volume":"9","author":"Stewart","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0033","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40425-018-0353-7","article-title":"Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events","volume":"6","author":"L\u00e4ubli","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0034","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/1471-2458-13-269","article-title":"Local public health response to vaccine-associated measles: case report","volume":"13","author":"Hau","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1525-1470.2005.22208.x","article-title":"Vaccine-associated \u201cwild-type\u201d measles","volume":"22","author":"Berggren","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0036","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-129-2-199807150-00007","article-title":"Vaccine-associated measles pneumonitis in an adult with AIDS","volume":"129","author":"Angel","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0037","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0038","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/S1473-3099(18)30601-7","article-title":"Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Mikulska","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0039","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0040","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41409-018-0112-x","article-title":"Safety of live attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation","volume":"53","author":"Pandit","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0041","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12519-008-0047-1","article-title":"Efficacy and safety of measles, mumps, rubella and varicella live viral vaccines in transplant recipients receiving immunosuppressive drugs","volume":"4","author":"Danerseau","year":"2008","journal-title":"World J Pediatr"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0042","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3109\/08880018.2013.877111","article-title":"Assessment of immune response following immunization with DTP\/Td and MMR vaccines in children treated for acute lymphoblastic leukemia","volume":"31","author":"Koochakzadeh","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0043","first-page":"147","article-title":"Application of live attenuated measles and mumps vaccines in children with acute leukemia","volume":"24","author":"Torigoe","year":"1981","journal-title":"Biken J"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0044","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1086\/319591","article-title":"Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children","volume":"32","author":"Berkelhamer","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/520651","article-title":"Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy","volume":"45","author":"Aurpibul","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0046","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1016\/j.vaccine.2011.02.013","article-title":"Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults","volume":"29","author":"Stermole","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0047","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.295.6589.15","article-title":"Measles in children who have malignant disease","volume":"295","author":"Kernahan","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0048","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bmj.295.6589.19","article-title":"Mortality and morbidity caused by measles in children with malignant disease attending four major treatment centres: a retrospective review","volume":"295","author":"Gray","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0049","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.1992.03480090085032","article-title":"Severe measles in immunocompromised patients","volume":"267","author":"Kaplan","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood.V99.1.83","article-title":"Measles in bone marrow transplant recipients during an outbreak in S\u00e3o Paulo, Brazil","volume":"99","author":"Machado","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0051","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0140-6736(76)91821-3","article-title":"Letter: Atypical measles encephalitis in leukaemic children in remission","volume":"2","author":"Smyth","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0052","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJM195910292611801","article-title":"Isolation of measles virus at autopsy in cases of giant-cell pneumonia without rash","volume":"261","author":"Enders","year":"1959","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0053","first-page":"339","article-title":"[Delayed acute measles encephalitis]","volume":"47","author":"Luna","year":"1990","journal-title":"Arch Fr Pediatr"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0054","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0387-7604(89)80061-0","article-title":"Acute measles encephalitis of the delayed type in an immunosuppressed child","volume":"11","author":"Colamaria","year":"1989","journal-title":"Brain Dev"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0055","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/clind\/16.5.654","article-title":"Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature","volume":"16","author":"Mustafa","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0056","unstructured":"Centers for Disease Control and Prevention. Transmission of measles. Available at:https:\/\/www.cdc.gov\/measles\/transmission.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fmeasles%2Fabout%2Ftransmission.html. Accessed 30 June 2019."},{"key":"10.1016\/j.bbmt.2019.07.034_bib0057","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.1985.03350350068022","article-title":"Airborne transmission of measles in a physician's office","volume":"253","author":"Remington","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0058","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5365\/wpsar.2012.3.3.009","article-title":"Measles transmission in health care waiting rooms: implications for public health response","volume":"3","author":"Hope","year":"2012","journal-title":"Western Pac Surveill Response J"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0059","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1086\/318533","article-title":"Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction","volume":"183","author":"Permar","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0060","unstructured":"Centers for Disease Control and Prevention. Measles (rubeola) for healthcare professionals. Available at: https:\/\/www.cdc.gov\/measles\/hcp\/index.html. Accessed 29 May 2019."},{"key":"10.1016\/j.bbmt.2019.07.034_bib0061","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1128\/JCM.43.10.5117-5121.2005","article-title":"Evaluation of diagnostic markers for measles virus infection in the context of an outbreak in Spain","volume":"43","author":"Mosquera","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0062","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/175.1.195","article-title":"Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset","volume":"175","author":"Helfand","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0063","first-page":"852","article-title":"The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas","volume":"82","author":"Dietz","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0064","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.4103\/0366-6999.206358","article-title":"Measles outbreak in pediatric hematology and oncology patients in Shanghai, 2015","volume":"130","author":"Ge","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0065","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1002\/pbc.24575","article-title":"Measles outbreak in a pediatric oncology unit and the role of ribavirin in prevention of complications and containment of the outbreak","volume":"60","author":"Roy Moulik","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0066","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200252","article-title":"Fatal measles pneumonitis during Hodgkin's lymphoma","volume":"2013","author":"Wyplosz","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0067","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy244","article-title":"Fatal measles virus infection after rituximab-containing chemotherapy in a previously vaccinated patient","volume":"5","author":"Jent","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0068","first-page":"338","article-title":"Giant cell pneumonia in a leukemic child in remission: a case report","volume":"43","author":"Kanra","year":"2001","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0069","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1055\/s-2007-1024096","article-title":"[Fatal course of measles infection in a patient with a low-grade malignant non-Hodgkin lymphoma]","volume":"123","author":"Klimkiewicz","year":"1998","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0925-5710(98)00079-6","article-title":"Diagnosis of measles viral pneumonia in a patient with Hodgkin's disease by reverse transcription-polymerase chain reaction of serum","volume":"68","author":"Mori","year":"1998","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0071","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mpd.2003.217","article-title":"Fever and respiratory distress in an 8-year-old boy receiving therapy for acute lymphoblastic leukemia","volume":"142","author":"Weitzman","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0072","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.aaa3662","article-title":"Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality","volume":"348","author":"Mina","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0073","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-065X.2010.00925.x","article-title":"Measles virus-induced suppression of immune responses","volume":"236","author":"Griffin","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0074","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1016\/j.vaccine.2018.07.030","article-title":"Subacute sclerosing panencephalitis mortality, United States, 1979-2016: vaccine-induced declines in SSPE deaths","volume":"36","author":"Pallivathucal","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0075","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1592\/phco.27.4.494","article-title":"Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome","volume":"27","author":"Muller","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0076","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/00365548409070407","article-title":"Possible interferon response in a child with measles encephalitis during immunosuppression","volume":"16","author":"Simpson","year":"1984","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0077","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1128\/jvi.69.9.5469-5474.1995","article-title":"Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis","volume":"69","author":"Finke","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0078","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00430-010-0153-2","article-title":"Measles virus infection of the CNS: human disease, animal models, and approaches to therapy","volume":"199","author":"Reuter","year":"2010","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0079","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/JVI.02417-14","article-title":"Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides","volume":"89","author":"Mathieu","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0080","doi-asserted-by":"crossref","first-page":"13785","DOI":"10.1128\/JVI.02436-13","article-title":"Fatal measles virus infection prevented by brain-penetrant fusion inhibitors","volume":"87","author":"Welsch","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0081","series-title":"Red Book 2018","first-page":"537","author":"Kimberlin","year":"2018"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0082","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/infdis\/jiv555","article-title":"Measles virus neutralizing antibody response, cell-mediated immunity, and immunoglobulin G antibody avidity before and after receipt of a third dose of measles, mumps, and rubella vaccine in young adults","volume":"213","author":"Fiebelkorn","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0083","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.bbmt.2017.06.006","article-title":"Measuring immune response to commonly used vaccinations in adult recipients of allogeneic hematopoietic cell transplantation","volume":"23","author":"Kennedy","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0084","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbmt.2017.12.795","article-title":"Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance","volume":"24","author":"Palazzo","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0085","unstructured":"Centers for Disease Control and Prevention. Recommended intervals between administration of antibody-containing products and measles- or varicella-containing vaccine. Available at: https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/appendices\/a\/mmr_ig.pdf. Accessed 3 June 2019."},{"key":"10.1016\/j.bbmt.2019.07.034_bib0086","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1182\/blood-2002-01-0212","article-title":"Safety of early immunization against measles\/mumps\/rubella after bone marrow transplantation","volume":"99","author":"Shaw","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0087","first-page":"633","article-title":"Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients","volume":"17","author":"King","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0088","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.vaccine.2015.01.075","article-title":"Effectiveness and safety of immunization with live attenuated and inactivated vaccines for pediatric liver transplantation recipients","volume":"33","author":"Kawano","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0089","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcv.2015.06.095","article-title":"Immune status of health care workers to measles virus: evaluation of protective titers in four measles IgG EIAs","volume":"69","author":"Dorigo-Zetsma","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0090","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V84.2.657.657","article-title":"Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation","volume":"84","author":"Ljungman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0091","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1158\/1078-0432.CCR-12-2422","article-title":"B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma","volume":"19","author":"Carpenter","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0092","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1182\/blood-2016-04-711903","article-title":"T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma","volume":"128","author":"Ali","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0093","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbmt.2016.09.002","article-title":"Chimeric antigen receptor T cells and hematopoietic cell transplantation: how not to put the CART before the horse","volume":"23","author":"Kenderian","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0094","first-page":"880","article-title":"The promise of chimeric antigen receptor T-cell therapy","volume":"30","author":"Frey","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0095","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/cpt.392","article-title":"CD19-Targeted chimeric antigen receptor-modified T-cell immunotherapy for B-cell malignancies","volume":"100","author":"Turtle","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0096","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.ymthe.2017.07.004","article-title":"Long-duration complete remissions of diffuse large B cell lymphoma after anti-CD19 chimeric antigen receptor T cell therapy","volume":"25","author":"Kochenderfer","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0097","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0098","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0099","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2017-07-793760","article-title":"Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy","volume":"131","author":"Hill","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0101","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/blood-2016-01-694356","article-title":"Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy","volume":"128","author":"Bhoj","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0102","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/infdis\/jis719","article-title":"Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age","volume":"207","author":"Gans","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0103","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.healthpol.2009.11.009","article-title":"Who is that masked person: the use of face masks on Mexico City public transportation during the influenza A (H1N1) outbreak","volume":"95","author":"Condon","year":"2010","journal-title":"Health Policy"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0104","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1016\/j.vaccine.2014.09.052","article-title":"Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines","volume":"32","author":"Keller-Stanislawski","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/517952","article-title":"Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient","volume":"28","author":"Kamboj","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0106","unstructured":"Pereira I. Some NYC hospitals demand vaccination records from visitors amid measles outbreak, amNew York. May 29, 2019. Available at:https:\/\/www.amny.com\/news\/measles-outbreak-nyc-hospitals-1.31721793. Accessed 18 June 2019."},{"key":"10.1016\/j.bbmt.2019.07.034_bib0107","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/ajt.15101","article-title":"Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation","volume":"19","author":"Pittet","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2019.07.034_bib0108","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119305063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119305063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:08:03Z","timestamp":1761059283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119305063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":108,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1083879119305063"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.07.034","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy","name":"copyright","label":"Copyright"}]}}